A. A. Anischenko

Statistics

Publications

Citations

202

H-Index

Active since

2001

Affiliations

Christian Medical College, Vellore(Current)

A. A. Anischenko is an author at Christian Medical College, Vellore specializing in vascular endothelial growth factor inhibition, medicine, and renal cell carcinoma.

Publications per year

2001–2012

Publications

Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients With Renal Cell Carcinoma

Dmitry Nosov, Brooke Esteves, Oleg Lipatov et al. · Journal of Clinical Oncology · 2012 · 126 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Updated activity and safety results of a phase II randomized discontinuation trial (RDT) of AV-951, a potent and selective VEGFR1, 2, and 3 kinase inhibitor, in patients with renal cell carcinoma (RCC)

Pankaj Bhargava, B. Esteves, Dmitry Nosov et al. · Journal of Clinical Oncology · 2009 · 31 citations

Medicine, Oncology, Pharmacotherapy +16

Activity of tivozanib (AV-951) in patients with renal cell carcinoma (RCC): Subgroup analysis from a phase II randomized discontinuation trial (RDT).

Pankaj Bhargava, B. Esteves, Mohammed Al-Adhami et al. · Journal of Clinical Oncology · 2010 · 24 citations

Medicine, Oncology, Pharmacotherapy +14

Heterocondensed 1,2,3‐diazaphosphorines

Sergey P. Ivonin, Andrew A. Tolmachev, A. A. Chaikovskaya et al. · Heteroatom Chemistry · 2001 · 21 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9

1–4 of 4